William Benton Jones - May 6, 2024 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
SVP, Pharmaceutical Development
Signature
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
Stock symbol
CRVS
Transactions as of
May 6, 2024
Transactions value $
$34,624
Form type
4
Date filed
5/7/2024, 05:06 PM
Previous filing
Dec 8, 2023
Next filing
Dec 23, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $34.6K +20K +14.95% $1.73 154K May 6, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Warrant (Right to Buy) Purchase +19.4K 19.4K May 6, 2024 Common Stock 19.4K $3.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.

Remarks:

SVP, Pharmaceutical Development